Loading
Vaccines and Immunoinformatics Approaches / Vaccine Coverage and Hesitancy · Journal article
Revista Fisio&terapia. · August 7, 2026
A consensus or society position rather than new primary data.
This integrative literature review synthesizes evidence on next-generation vaccine platforms (mRNA, plasmid DNA, viral vectors, recombinant proteins) and reports that they promote more efficient humoral and cellular immune responses compared to conventional vaccination. The review identifies key challenges (stability, logistics, variant surveillance, vaccine hesitancy) and advocates for sustained investment in research and public health infrastructure.
Integrative literature review. Evidence on next-generation vaccine platforms and immunological mechanisms for biomedical sciences; no specific patient population studied..
mRNA, plasmid DNA, recombinant viral vectors, and recombinant proteins platforms promote more efficient humoral and cellular immune responses than conventional vaccination Next-generation vaccines expand possibilities for precision medicine and immunotherapy Key challenges identified: vaccine stability, distribution logistics, emerging variant surveillance, vaccine hesitancy, and need for strengthened research and national production
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians and researchers should regard this review as a synthesis of current knowledge on vaccine platform technologies and immunological mechanisms rather than evidence from comparative trials. The identified challenges—particularly stability, logistics, and variant surveillance—warrant attention in implementation planning.
This is a narrative literature review synthesizing evidence on next-generation vaccine platforms and mechanisms; it provides descriptive synthesis rather than original data or comparative effectiveness evidence.
As stated by the source record.
Clinicians and researchers should regard this review as a synthesis of current knowledge on vaccine platform technologies and immunological mechanisms rather than evidence from comparative trials. The identified challenges—particularly stability, logistics, and variant surveillance—warrant attention in implementation planning.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Advances in immunology and biotechnology have driven the development of next-generation vaccines capable of inducing more specific, safer, and more effective immune responses, expanding the possibilities for preventing and treating a wide range of diseases. This study aimed to analyze the scientific evidence regarding the immunological mechanisms, main vaccine platforms, clinical applications, and future perspectives of next-generation vaccines for Biomedical Sciences. This qualitative, descriptive, and exploratory study was conducted through an integrative literature review. The bibliographic search was performed in the SciELO, PubMed/MEDLINE, Virtual Health Library (VHL), Google Scholar, Web of Science, and Scopus databases, complemented by technical and institutional documents published between 2016 and 2026. The analyzed evidence demonstrated that platforms such as messenger RNA, plasmid DNA, recombinant viral vectors, and recombinant proteins represent a significant advancement over conventional vaccination by promoting more efficient humoral and cellular immune responses and expanding the possibilities of precision medicine and immunotherapy. The studies also highlighted challenges related to vaccine stability, distribution logistics, surveillance of emerging variants, vaccine hesitancy, and the need to strengthen research and national production of immunobiological products. It is concluded that next-generation vaccines represent one of the most important innovations in contemporary Biomedical Sciences, contributing to the improvement of immunization strategies and the development of more personalized therapeutic approaches. However, their consolidation will depend on continued investment in scientific research, technological innovation, professional training, and the strengthening of public health policies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.